Literature DB >> 30625362

Relative reduction of biological and phylogenetic diversity of the oral microbiota of diabetes and pre-diabetes patients.

Amr T M Saeb1, Khalid A Al-Rubeaan2, Khalid Aldosary3, G K Udaya Raja4, Balavenkatesh Mani4, Mohamed Abouelhoda5, Hamsa T Tayeb6.   

Abstract

BACKGROUND: A reciprocal relationship between oral health and systemic disease, such as type 2 diabetes, has been suggested, whereby a systemic disease is a predisposing factor for oral infection. If the infection occurs, it in turn aggravates the progression of the systemic disease. According to several studies, certain constituents of the oral microbiota are linked to diabetes, metabolic syndrome, and obesity. In the current study, we aimed to compare the microbial diversity and population structure of the oral microbiota of normoglycemic, impaired glucose tolerance (IGT), and diabetes patients.
METHODOLOGY: The study followed a case-control design, with 15 type 2 diabetes patients, 10 IGT subjects, and 19 control subjects. All subjects underwent assessment of periodontitis and oral health. Saliva samples were collected, and DNA was isolated from these samples. Hypervariable regions of the 16Sr RNA gene were amplified and sequenced, and the generated sequences underwent bioinformatics analysis. Statistical analysis and diversity index calculations were made using the statistical software R, vegan R-package, and Past3.20 software.
RESULTS: Overall, 551 operational taxonomic units (OTUs) were identified. Based on OTU analysis, a clear reduction of the number of species was observed in both IGT (412) and diabetes groups (372) compared with that in the normoglycemic group (502). This was associated with a similar pattern of reduction of biological diversity among the three groups. The phylogenetic diversity (PD-SBL) value in the normoglycemic group was higher than that in the diabetes group. The diabetes group exhibited the highest evenness value and the highest microbiota bacterial pathogenic content.
CONCLUSION: A clear reduction of the biological and phylogenetic diversity was apparent in the diabetes and pre-diabetes oral microbiota in comparison with that in the normoglycemic oral microbiota. However, this was associated with an increase in the pathogenic content of the hyperglycemic microbiota. The results of this study may aid to better understanding of the directionality of the mysterious reciprocal relationship.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  16S rRNA; Biological diversity; Diabetes; Impaired glucose tolerance; Ion torrent; Next-generation sequencing; Operational taxonomic unit; Oral microbiota; Phylogenetic diversity

Mesh:

Substances:

Year:  2019        PMID: 30625362     DOI: 10.1016/j.micpath.2019.01.009

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  23 in total

1.  Enrichment of sulphate-reducers and depletion of butyrate-producers may be hyperglycaemia signatures in the diabetic oral microbiome.

Authors:  Camilla Pedrosa Vieira Lima; Daniela Corrêa Grisi; Maria Do Carmo Machado Guimarães; Loise Pedrosa Salles; Paula de Castro Kruly; Thuy Do; Luiz Gustavo Dos Anjos Borges; Naile Dame-Teixeira
Journal:  J Oral Microbiol       Date:  2022-06-03       Impact factor: 5.833

2.  Alterations in the Oral Microbiome Associated With Diabetes, Overweight, and Dietary Components.

Authors:  Abeer Shaalan; Sunjae Lee; Catherine Feart; Esther Garcia-Esquinas; David Gomez-Cabrero; Esther Lopez-Garcia; Martine Morzel; Eric Neyraud; Fernando Rodriguez-Artalejo; Ricarda Streich; Gordon Proctor
Journal:  Front Nutr       Date:  2022-07-06

3.  Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol.

Authors:  Peng-Xiang Zhang; Lin Zeng; Lu Meng; Hui-Lin Li; Heng-Xia Zhao; De-Liang Liu
Journal:  BMC Complement Med Ther       Date:  2022-10-19

4.  Characterization of salivary microbiota in elderly patients with type 2 diabetes mellitus: a matched case-control study.

Authors:  Michi Omori; Nahoko Kato-Kogoe; Shoichi Sakaguchi; Kuniyasu Kamiya; Nozomu Fukui; Yan-Hong Gu; Shota Nakamura; Takashi Nakano; Masaaki Hoshiga; Akihisa Imagawa; Chee Hoe Kit; Junko Tamaki; Takaaki Ueno
Journal:  Clin Oral Investig       Date:  2021-06-18       Impact factor: 3.606

5.  Changes of saliva microbiota in the onset and after the treatment of diabetes in patients with periodontitis.

Authors:  Ying Yang; Shili Liu; Yihua Wang; Zhibin Wang; Wenyu Ding; Xiaoyuan Sun; Kunlun He; Qiang Feng; Xiandang Zhang
Journal:  Aging (Albany NY)       Date:  2020-07-07       Impact factor: 5.682

6.  Subgingival Microbiota of Mexicans with Type 2 Diabetes with Different Periodontal and Metabolic Conditions.

Authors:  Adriana-Patricia Rodríguez-Hernández; María de Lourdes Márquez-Corona; América Patricia Pontigo-Loyola; Carlo Eduardo Medina-Solís; Laurie-Ann Ximenez-Fyvie
Journal:  Int J Environ Res Public Health       Date:  2019-08-31       Impact factor: 3.390

Review 7.  The salivary microbiota in health and disease.

Authors:  Daniel Belstrøm
Journal:  J Oral Microbiol       Date:  2020-02-04       Impact factor: 5.474

8.  Comparison of oral microbiome profiles in stimulated and unstimulated saliva, tongue, and mouth-rinsed water.

Authors:  Ryutaro Jo; Yuichiro Nishimoto; Kouta Umezawa; Kazuma Yama; Yuto Aita; Yuko Ichiba; Shinnosuke Murakami; Yasushi Kakizawa; Takashi Kumagai; Takuji Yamada; Shinji Fukuda
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

Review 9.  Management of an emergency tooth extraction in diabetic patients on the dental chair.

Authors:  Giath Gazal
Journal:  Saudi Dent J       Date:  2019-08-05

10.  A pilot study of red complex and three genera subgingival microbiome in periodontitis subjects with and without diabetes, evaluated by MinION platform.

Authors:  Boy M Bachtiar; Citra F Theodorea; Dicky L Tahapary; Cindy Astrella; Natalina -; Endang W Bachtiar
Journal:  F1000Res       Date:  2021-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.